Year
2019
Status
Active
Team
Field
cardio-metabolic
Location
Naarden (NL)
Fund
BGV II
NewAmsterdam Pharma
NewAmsterdam Pharma acquired Dezima Pharma and is now a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.